Search and rescue finding ways to correct ΔF508 CFTR

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 4, 2009, Pages 385-387

  Collawn, James F ^a   Bebok, Zsuzsa ^a   Matalon, Sadis ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; CHAPERONE; CURCUMIN; MUTANT PROTEIN; NITRIC OXIDE DONOR; SALMETEROL; THAPSIGARGIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; BETA 2 ADRENERGIC RECEPTOR; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508; DRUG DERIVATIVE; SALBUTAMOL;

AMINO ACID SUBSTITUTION; DRUG MECHANISM; EDITORIAL; GENE MUTATION; GENE THERAPY; HUMAN; LUNG FIBROSIS; NONHUMAN; PROTEIN FOLDING; PROTEIN STABILITY; BIOLOGICAL MODEL; CHANNEL GATING; CYSTIC FIBROSIS; DRUG EFFECT; GENETICS; METABOLISM; MUTATION;

ALBUTEROL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; ION CHANNEL GATING; MODELS, BIOLOGICAL; MUTATION; PROTEIN FOLDING; RECEPTORS, ADRENERGIC, BETA-2;

EID: 63349109752     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0006ED     Document Type: Editorial

References (35)

1. Herczenik E, Gebbink MF. Molecular and cellular aspects of protein misfolding and disease. FASEB J 2008;22:2115-2133.
2. Turnbull EL, Rosser MF, Cyr DM. The role of the UPS in cystic fibrosis. BMC Biochem 2007;8:S11.
3. Proesmans M, Vermeulen F, De Boeck K. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Eur J Pediatr 2008;167:839-849.
4. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992;358:761-764.
5. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 1991;354:526-528.
6. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996;271:635-638.
7. Egan ME, Glockner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S,Wagner CA,Geibel J,etal.Calcium-pump inhibitors induce functional surface expression of delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 2002;8:485-492.
8. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner- Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004; 304:600-602.
9. Zaman K, McPherson M, Vaughan J, Hunt J, Mendes F, Gaston B, Palmer LA. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochem Biophys Res Commun 2001;284:65-70.
10. Zaman K, Carraro S, Doherty J, Henderson EM, Lendermon E, Liu L, Verghese G, Zigler M, Ross M, Park E, et al. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells. Mol Pharmacol 2006;70:1435-1442.
11. Rubenstein RC, Zeitlin PL. Sodium 4-phenylbutryate downregulates HSC70: implications for intracellular trafficking of ΔF508-CFTR. Am J Physiol 2000;278:C259-C267.
12. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS. Small-molecule correctors of defective deltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 2005;115:2564-2571.
13. Van Goor F, Straley KS, Cao D, Gonzalez J, Hadida S, Hazlewood A, Joubran J, Knapp T, Makings LR, Miller M, et al. Rescue of deltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol 2006;290:L1117-L1130.
14. Carlile GW, Robert R, Zhang D, Teske KA, Luo Y, Hanrahan JW, Thomas DY. Correctors of protein trafficking defects identified by a novel high-throughput screening assay. ChemBioChem 2007;8:1012- 1020.
15. Robert R, Carlile GW, Pavel C, Liu N, Anjos SM, Liao J, Luo Y, Zhang D, Thomas DY, Hanrahan JW. Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect. Mol Pharmacol 2008;73:478-489.
16. Delavoie F, Molinari M, Milliot M, Zahm J-M, Coraux C, Michel J, Balossier G. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells. Am J Respir Cell Mol Biol 2009; 40:388-397.
17. Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, Cohn JA, Wilson JM. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992;2:240-248.
18. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, Boucher RC. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005;16:2154-2167.
19. Wu JV, Krouse ME, Wine JJ. Acinar origin of CFTR-dependent airway submucosal gland fluid secretion. Am J Physiol 2007;292:L304-L311.
20. Uezono Y, Bradley J, Min C, McCarty NA, Quick M, Riordan JR, Chavkin C, Zinn K, Lester HA, Davidson N. Receptors that couple to 2 classes of G proteins increase camp and activate CFTR expressed in xenopus oocytes. Receptors Channels 1993;1:233-241.
21. Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, Liao J, Kirk KL, Sorscher EJ, Hanrahan J, et al. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phos-phoprotein 50 is regulated by PKA. Proc Natl Acad Sci USA 2003; 100:342-346.
22. Widdicombe JH. Cystic fibrosis and beta-adrenergic response of airway epithelial cell cultures. Am J Physiol 1986;251:R818-R822.
23. 2+ ionophores in cystic fibrosis airway epithelia. Am J Physiol 1989;256:C226-C233.
24. Taouil K, Hinnrasky J, Hologne C, Corlieu P, Klossek JM, Puchelle E. Stimulation of beta 2-adrenergic receptor increases cystic fibrosis transmembrane conductance regulator expression in human airway epithelial cells through a cAMP/protein kinase a-independent pathway. J Biol Chem 2003;278:17320-17327.
25. Moyer BD, Denton J, Karlson KH, Reynolds D, Wang S, Mickle JE, Milewski M, Cutting GR, Guggino WB, Li M, et al. A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest 1999;104:1353-1361.
26. + exchanger regulator factor family of PDZ proteins. Proc Natl Acad Sci USA 1998;95:8496-8501.
27. + exchange. Nature 1998;392:626-630.
28. + exchanger regulatory factor potentiates receptor activity. Mol Cell Biol 2000;20:8352-8363.
29. Swiatecka-Urban A, Duhaime M, Coutermarsh B, Karlson KH, Collawn J, Milewski M, Cutting GR, Guggino WB, Langford G, Stanton BA. PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 2002; 277:40099-40105.
30. Baconnais S, Delavoie F, Zahm JM, Milliot M, Terryn C, Castillon N, Banchet V, Michel J, Danos O, Merten M, et al. Abnormal ion content, hydration and granule expansion of the secretory granules from cystic fibrosis airway glandular cells. Exp Cell Res 2005;309:296-304.
31. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB. Sustained activation of a G protein-coupled receptor via ''anchored'' agonist binding: molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem 1996;271:24029-24035.
32. January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, Clark RB. Salmeterol-induced desensitization, internal-ization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol 1998;123:701-711.
33. Moore RH, Millman EE, Godines V, Hanania NA, Tran TM, Peng H, Dickey BF, Knoll BJ, Clark RB. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol 2007;36:254-261.
34. Prince LS, Workman RB Jr, Marchase RB. Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 1994;91:5192-5196.
35. Davis IC, Xu A, Gao Z, Hickman-Davis JM, Factor P, Sullender WM, Matalon S. Respiratory syncytial virus induces insensitivity to b-adrenergic agonists in mouse lung epithelium in vivo. Am J Physiol 2007;293:L281-L289.